Quantcast

Latest Boston Scientific Corporation Stories

2014-05-01 08:37:26

Promising Clinical Data to be Presented at Annual Conference NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will present select abstracts and clinical data analyses pertaining to key issues in gastroenterology during Digestive Disease Week (DDW(®)) 2014, May 4-6 in Chicago. Data presentations will include the Boston Scientific SpyGlass((TM)) Direct Visualization System, the Resolution((TM)) Clip and the recently FDA cleared and CE marked...

2014-05-01 08:36:48

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2014 Healthcare Conference on May 13 in Las Vegas, NV. Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 5:00 p.m. PT. A live webcast of the question and answer session will be available to interested parties via the Boston...

2014-05-01 00:21:42

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced DES system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval. "It is my great pleasure to be able to provide the Promus PREMIER(TM) Stent System to physicians and patients in Japan,"...

2014-04-29 08:34:19

Company Exceeds Earnings Per Share Guidance on the Strength of Continued Revenue Growth NATICK, Mass., April 29, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $1.774 billion during the first quarter ended March 31, 2014. This represents 4 percent operational revenue growth (constant currency basis, excluding divested businesses) and 1 percent revenue growth on a reported basis, all compared to the prior year period. The company also achieved adjusted...

2014-04-22 08:35:03

NATICK, Mass., April 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY(TM) X4 left-ventricular (LV) pacing leads and RELIANCE(TM) 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to establish the safety and effectiveness of both lead families and is intended to support U.S. Food and Drug Administration (FDA) approval of these devices. ACUITY X4 LV leads are...

2014-04-17 08:29:03

Event Will Be Held in San Francisco, Site of the Heart Rhythm Society 35th Annual Scientific Sessions NATICK, Mass., April 17, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event on May 8, 2014 to provide an update on company Cardiac Rhythm Management and Electrophysiology initiatives as well as developments and technologies in connection with its attendance at the 2014 Annual Heart Rhythm Society Scientific Session in San Francisco, CA. The...

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN(TM) MINI and INOGEN(TM) MINI ICDs, as well as the DYNAGEN(TM) X4 and INOGEN(TM) X4 CRT-Ds. The X4 line of quadripolar CRT-Ds offers 70 percent more pacing options to address high capture thresholds and phrenic nerve...

2014-04-02 00:23:28

These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease NATICK, Mass., April 1, 2014 /PRNewswire/ -- Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and...

2014-04-01 16:25:47

NATICK, Mass., April 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2014 on Tuesday, April 29, 2014 at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. A live webcast of the conference call will be available via Boston Scientific's website. Webcast...

2014-04-01 12:32:58

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsMediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsSummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related